Next Pharmaceutical Technologies is a research and development company working across the life sciences. We bring formulation, analytical, quality and process development together under one programme — so the decisions made in early development still hold when a product reaches transfer and scale-up.
Integrated technical expertise, delivered to national and international standards.
Formulation design and optimisation alongside the process that has to produce it, from early feasibility work through to a robust late-stage process. Developing both together is what keeps a formulation manufacturable rather than merely elegant on paper.
Methods developed for the product and the stage it is at, then validated so results stand up to scrutiny. Analytical capability underpins every other part of a development programme, which is why we build it in from the start rather than retrofitting it.
Stability study design and execution, specification setting, and the quality work that supports them. The evidence generated here defines shelf life, storage conditions and the claims that can be made about the product.
Moving a process from development to production scale, and between sites, with the documentation and comparability work that makes the transfer defensible. Scale-up studies establish what changes with batch size and what must not.
Support for licensing and technology transfer arrangements, together with coordination of clinical and preclinical development activities — keeping technical, regulatory and programme timelines aligned rather than negotiated after the fact.
Innovation-driven projects involving software, digital tooling and applied artificial intelligence models for life-science applications. This work runs in parallel with our development programmes and informs them.
We work at any stage, and most often across several. Programmes can begin with us or join us partway.
Early stage
Preformulation and candidate work, initial analytical groundwork, and an honest assessment of what the intended product will require — technically and commercially — before significant investment is committed.
Late stage
Formulation and process optimisation, analytical method validation, stability programmes and specification setting: the body of evidence that a product is reproducible and understood.
Transfer
Technology transfer to the receiving site, scale-up studies, and the documentation that carries the programme into routine production.
Next Pharmaceutical Technologies is a research and development company operating across the life sciences from Ankara, Türkiye.
We deliver scientific and technical solutions aligned with national and international standards, spanning early-stage and late-stage development. Our work covers R&D, formulation and process development, analytical method development and validation, quality and stability, technology transfer and scale-up studies — and we support clients through licensing arrangements and the coordination of clinical and preclinical development activities.
In parallel, we pursue innovation-driven projects involving digital solutions, software and applied artificial intelligence models for life-science applications.
We collaborate with national and international funding bodies, academic institutions and industry partners on research, development and technology-driven initiatives. Our facilities are located at the Lokman Hekim University Health and Drug Technology Centre (LHUSTEK) in Ankara.
Tell us about the product or programme and the stage it has reached. We will tell you plainly whether it is work we are the right people for.
Next İlaç Araştırma ve Geliştirme A.Ş. Lokman Hekim Üniversitesi Sağlık ve İlaç Teknoloji Merkezi (LHUSTEK)